Company / Book Value per Share
Cytokinetics Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$5.5K
FY2025
5-year range
-$5.5K / $2.876
FY2021-FY2025
Trend
-412254.0%
vs FY2024
Sector context
#209 of 209
Health Care
What the data says
Book Value per Share changed -412254% YoY in FY2025, a notable deviation from the 9-year average annual change of -45748%.
Based on SEC 10-K filings.
-$5,492.161 in FY2025.
Declined from -$4.074 to -$5,492.161 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 209This company -$5.5K Sector average $189.406
▼
-2999.7% below sector average
Key checks
Key Insights
- In FY2025, book value per share decreased 412254.0% year-over-year.
- Ranks #209 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.5K | -412254.0% |
| FY2024 | -$1.332 | +67.3% |
| FY2023 | -$4.074 | -220.2% |
| FY2022 | -$1.272 | -144.2% |
| FY2021 | $2.876 | +80.1% |
| FY2020 | $1.597 | +963.8% |
| FY2019 | -$0.185 | -139.0% |
| FY2018 | $0.474 | -76.7% |
| FY2017 | $2.036 | -12.3% |
| FY2016 | $2.321 | +34.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026